The mouse-lethal H5N1 influenza virus carrying the PB2-384L/443R/460M characteristics acquired in avian hosts can
Weipeng Lin1, Guohua Deng1, Xin Xing1
1State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute, CAAS, Harbin, People's Republic of China.
Abstract:
The species-specific acidic nuclear phosphoprotein 32 kDa members (ANP32A/B) play a key role in restricting the function of avian influenza virus polymerase in mammalian host. Avian influenza viruses, upon replicating in humans, may acquire critical amino acid substitutions in the polymerase basic 2 (PB2) protein (e.g. E627 K and D701N) that enhance the viral polymerase's functional compatibility with human ANP32A and ANP32B proteins, thereby augmenting viral replication efficiency and increasing pathogenic potential in humans. However, certain H5N1 avian influenza viruses have demonstrated the capacity to establish productive human infections in the absence of the canonical PB2-627 K or PB2-701N adaptive mutations; the underlying molecular mechanism remains incompletely characterized. In this study, we found that the two H5N1 viruses, namely A/chicken/LN/SD035/2018 (LN35) and A/duck/JL/S1261/2019 (JL261), were genetically similar, but their pathogenicity for mice was different. By evaluating a series of single-gene reassortant viruses and mutants in mice, we confirmed that the PB2-384L/443R/460M characteristics are crucial for LN35 to maintain high lethality in mice. We further revealed that the polymerase of H5N1 avian virus bearing PB2-384L/443R/460M signature could efficiently utilize human ANP32A/B. Moreover, we found that this PB2-384L/443R/460M signature positively regulates H5N1 vRNP-human ANP32A/B interaction and vRNP assembly. Our findings indicate that key amino acid substitutions in the PB2 gene of the H5N1 virus may emerge in avian host and then augment its capacity to interact with human ANP32A/B protein, underscoring the substantial zoonotic and public health risks associated with continued circulation and evolution of H5N1 in avian populations.
Insights
H5N1 avian influenza viruses can infect humans without common adaptive mutations. Specific PB2 protein changes (PB2-384L/443R/460M) enhance interaction with human ANP32A/B, increasing H5N1 virus lethality and zoonotic risk.
Area of Science:
- Virology
- Molecular Biology
- Public Health
Background:
- Acidic nuclear phosphoprotein 32 kDa members (ANP32A/B) restrict avian influenza virus polymerase in mammals.
- Avian influenza viruses often acquire PB2 mutations (e.g., E627K, D701N) for human adaptation.
- Some H5N1 viruses infect humans without these canonical mutations, necessitating further investigation.
Purpose of the Study:
- To elucidate the molecular mechanisms behind H5N1 avian influenza virus adaptation to human hosts.
- To identify specific viral factors enabling H5N1 replication in humans independent of known adaptive mutations.
- To assess the zoonotic potential and public health implications of H5N1 evolution.
Main Methods:
- Comparative analysis of H5N1 virus strains (A/chicken/LN/SD035/2018 and A/duck/JL/S1261/2019) in mice.
- Construction and evaluation of single-gene reassortant viruses and mutants.
- Assessment of viral polymerase activity and interaction with human ANP32A/B proteins.
Main Results:
- The PB2 protein signature (384L/443R/460M) was critical for the high lethality of the LN35 H5N1 strain in mice.
- This PB2 signature enables efficient utilization of human ANP32A/B by the H5N1 virus polymerase.
- The PB2-384L/443R/460M signature enhances H5N1 virus-RNA ribonucleoprotein (vRNP) interaction with human ANP32A/B and promotes vRNP assembly.
Conclusions:
- Key amino acid substitutions in the H5N1 virus PB2 gene can emerge in avian hosts, enhancing its ability to interact with human ANP32A/B.
- These adaptations increase the virus's replication efficiency and pathogenic potential in humans.
- The findings highlight the significant zoonotic and public health risks posed by the continued circulation and evolution of H5N1 in avian populations.
Related Concept Videos
Influenza
Leaky Scanning
Viral Recombination
Inhibitors Of Virion Release
Viral Mutations


